REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 63 filers reported holding REPARE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,135,655 | +14.2% | 3,322,488 | 0.0% | 0.85% | +33.9% |
| Q2 2023 | $35,151,923 | +7.5% | 3,322,488 | 0.0% | 0.64% | -0.8% |
| Q1 2023 | $32,693,282 | -33.1% | 3,322,488 | 0.0% | 0.64% | -31.3% |
| Q4 2022 | $48,873,798 | +21.3% | 3,322,488 | 0.0% | 0.94% | +25.0% |
| Q3 2022 | $40,302,000 | -13.3% | 3,322,488 | 0.0% | 0.75% | -11.2% |
| Q2 2022 | $46,482,000 | -1.8% | 3,322,488 | 0.0% | 0.84% | +9.8% |
| Q1 2022 | $47,312,000 | -32.5% | 3,322,488 | 0.0% | 0.77% | -14.9% |
| Q4 2021 | $70,071,000 | -19.6% | 3,322,488 | 0.0% | 0.90% | -5.9% |
| Q3 2021 | $87,182,000 | -18.4% | 3,322,488 | -3.0% | 0.96% | -11.4% |
| Q2 2021 | $106,833,000 | +1.6% | 3,426,325 | 0.0% | 1.08% | +10.0% |
| Q1 2021 | $105,154,000 | -10.5% | 3,426,325 | 0.0% | 0.98% | -4.4% |
| Q4 2020 | $117,523,000 | +11.5% | 3,426,325 | 0.0% | 1.03% | -22.4% |
| Q3 2020 | $105,428,000 | -0.8% | 3,426,325 | 0.0% | 1.32% | -11.4% |
| Q2 2020 | $106,285,000 | – | 3,426,325 | – | 1.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,560,703 | $78,588,000 | 15.73% |
| MPM ASSET MANAGEMENT LLC | 2,603,089 | $79,889,000 | 15.43% |
| MPM BioImpact LLC | 2,069,749 | $63,521,000 | 7.98% |
| BVF INC/IL | 3,722,398 | $114,240,000 | 4.28% |
| StepStone Group LP | 8,721 | $268,000 | 4.12% |
| Logos Global Management LP | 900,000 | $27,621,000 | 2.70% |
| Redmile Group, LLC | 2,665,496 | $81,804,000 | 1.15% |
| Orbimed Advisors | 3,426,325 | $105,154,000 | 0.98% |
| Soleus Capital Management, L.P. | 133,324 | $4,092,000 | 0.74% |
| SPHERA FUNDS MANAGEMENT LTD. | 248,100 | $7,614,000 | 0.58% |